- Home
- PCRX vs CTOS Comparison
PCRX vs CTOS Comparison
Compare PCRX & CTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- CTOS
- Stock Information
- Founded
- PCRX 2006
- CTOS 1988
- Country
- PCRX United States
- CTOS United States
- Employees
- PCRX N/A
- CTOS N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- CTOS Diversified Commercial Services
- Sector
- PCRX Health Care
- CTOS Consumer Discretionary
- Exchange
- PCRX Nasdaq
- CTOS Nasdaq
- Market Cap
- PCRX 1.2B
- CTOS 1.4B
- IPO Year
- PCRX 2011
- CTOS N/A
- Fundamental
- Price
- PCRX $23.63
- CTOS $6.21
- Analyst Decision
- PCRX Buy
- CTOS Buy
- Analyst Count
- PCRX 5
- CTOS 3
- Target Price
- PCRX $32.40
- CTOS $6.83
- AVG Volume (30 Days)
- PCRX 532.5K
- CTOS 809.8K
- Earning Date
- PCRX 11-05-2025
- CTOS 10-29-2025
- Dividend Yield
- PCRX N/A
- CTOS N/A
- EPS Growth
- PCRX N/A
- CTOS N/A
- EPS
- PCRX N/A
- CTOS N/A
- Revenue
- PCRX $705,848,000.00
- CTOS $1,901,675,000.00
- Revenue This Year
- PCRX $7.36
- CTOS $13.58
- Revenue Next Year
- PCRX $10.07
- CTOS $5.18
- P/E Ratio
- PCRX N/A
- CTOS N/A
- Revenue Growth
- PCRX 2.25
- CTOS 6.21
- 52 Week Low
- PCRX $15.16
- CTOS $3.03
- 52 Week High
- PCRX $27.64
- CTOS $6.64
- Technical
- Relative Strength Index (RSI)
- PCRX 32.49
- CTOS 53.56
- Support Level
- PCRX $24.31
- CTOS $6.28
- Resistance Level
- PCRX $26.05
- CTOS $6.59
- Average True Range (ATR)
- PCRX 0.76
- CTOS 0.24
- MACD
- PCRX -0.33
- CTOS 0.03
- Stochastic Oscillator
- PCRX 6.34
- CTOS 61.98
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About CTOS Custom Truck One Source Inc.
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.